Creative Minds & Smart Executive Team
Our strength lies in our talented team of professionals, each driven by a shared passion for innovation and excellence. Get to know the faces behind our success.
Amad S
CEO
As the CEO of Biosysion, Amad S provides visionary leadership and strategic direction, guiding our mission to transform early detection and diagnosis in critical diseases. With a proven track record of success across healthcare and diversified sectors, Amad drives our commitment to pioneering solutions that empower both patients and healthcare providers.
Zhao, Lijun
Vice President
As the Vice President of Research at Biosysion, Cambridge UK, Zhao Lijun drives the company’s scientific innovation and research strategy, leading the development of advanced diagnostic solutions. With deep expertise in medical device research and translational science, Zhao ensures that Biosysion delivers impactful, high-quality technologies that enhance patient care and empower healthcare providers.
Sara A
Senior Vice President
Sara is Senior Vice President and Head of Biosysion, leading strategy, partnerships, and commercialisation across the region. Based in Cambridge, UK, she drives the rollout of early-detection solutions like ColoCam® and PCR-based platforms, expanding access to affordable cancer screening.
Richard H
CTO
Guiding our diagnostic strategy is Richard, our Chief Technology Officer. With extensive experience in clinical diagnostics and laboratory medicine, Richard oversees the development and validation of diagnostic assays and tests for early detection, prognostication, and monitoring of cancers and critical diseases.
Harvey Johnson
CFO
Managing our financial strategy and operations is Harvey Johnson, Our Chief Financial Officer. With a focus on financial stewardship and growth, Harvey oversees financial planning, budgeting, and investment decisions to support Biosysion's mission of advancing early detection and molecular diagnostics in critical diseases.